E
VentriPoint Diagnostics Ltd. VPT.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income 40.48% 10.21% 24.19% 16.75% -4.77%
Total Depreciation and Amortization -1.75% -4.35% -12.50% -9.84% -7.32%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -74.48% 307.46% 270.04% -86.38% 366.19%
Change in Net Operating Assets 1,500.00% 32.04% 53.78% 160.19% -152.36%
Cash from Operations 86.28% 50.83% 66.37% 29.37% 29.96%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -101.47% -91.11% -- -- --
Total Debt Repaid -3.06% -3.06% 56.34% 0.00% -10.11%
Issuance of Common Stock -99.77% -- 19.41% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 16.42% 100.00% -- -- --
Cash from Financing -114.88% -60.54% 1,883.47% 2,438.89% 1,900.00%
Foreign Exchange rate Adjustments -245.61% 741.18% 103.77% -393.26% 178.08%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 8.33% -48.13% 129.84% 95.17% 80.96%